185 related articles for article (PubMed ID: 33281478)
1. The potential of Paritaprevir and Emetine as inhibitors of SARS-CoV-2 RdRp.
Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
Saudi J Biol Sci; 2021 Feb; 28(2):1426-1432. PubMed ID: 33281478
[TBL] [Abstract][Full Text] [Related]
2.
Gurung AB
Gene Rep; 2020 Dec; 21():100860. PubMed ID: 32875166
[TBL] [Abstract][Full Text] [Related]
3. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.
Wakchaure PD; Ghosh S; Ganguly B
J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493
[TBL] [Abstract][Full Text] [Related]
4. Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase.
Zhang L; Zhou R
J Phys Chem B; 2020 Aug; 124(32):6955-6962. PubMed ID: 32521159
[TBL] [Abstract][Full Text] [Related]
5. Screening of potent drug inhibitors against SARS-CoV-2 RNA polymerase: an in silico approach.
Singh SK; Upadhyay AK; Reddy MS
3 Biotech; 2021 Feb; 11(2):93. PubMed ID: 33520579
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Remdesivir in Comparison with Five Approved Antiviral Drugs for Inhibition of RdRp in Combat with SARS-CoV-2.
Mahdian S; Arab SS
Iran J Sci Technol Trans A Sci; 2022; 46(5):1359-1367. PubMed ID: 36187298
[TBL] [Abstract][Full Text] [Related]
7. Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: an
Ogunyemi OM; Gyebi GA; Elfiky AA; Afolabi SO; Ogunro OB; Adegunloye AP; Ibrahim IM
Antivir Chem Chemother; 2020; 28():2040206620984076. PubMed ID: 33372806
[TBL] [Abstract][Full Text] [Related]
8. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
[TBL] [Abstract][Full Text] [Related]
9.
Pandey K; Lokhande KB; Swamy KV; Nagar S; Dake M
Bioinform Biol Insights; 2021; 15():11779322211027403. PubMed ID: 34248355
[TBL] [Abstract][Full Text] [Related]
10. Teriflunomide: A possible effective drug for the comprehensive treatment of COVID-19.
Rabie AM
Curr Res Pharmacol Drug Discov; 2021; 2():100055. PubMed ID: 34870153
[TBL] [Abstract][Full Text] [Related]
11. Repurposing FDA-approved phytomedicines, natural products, antivirals and cell protectives against SARS-CoV-2 (COVID-19) RNA-dependent RNA polymerase.
Kandeel M; Kitade Y; Almubarak A
PeerJ; 2020; 8():e10480. PubMed ID: 33335812
[TBL] [Abstract][Full Text] [Related]
12. RNA dependent RNA polymerase (RdRp) as a drug target for SARS-CoV2.
Mishra A; Rathore AS
J Biomol Struct Dyn; 2022 Aug; 40(13):6039-6051. PubMed ID: 33491569
[TBL] [Abstract][Full Text] [Related]
13. Identification of FDA-approved drugs against SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) through computational virtual screening.
Jade D; Alzahrani A; Critchley W; Ponnambalam S; Harrison MA
Struct Chem; 2023; 34(3):1005-1019. PubMed ID: 36467260
[TBL] [Abstract][Full Text] [Related]
14. In silico studies of selected multi-drug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV.
Udofia IA; Gbayo KO; Oloba-Whenu OA; Ogunbayo TB; Isanbor C
Netw Model Anal Health Inform Bioinform; 2021; 10(1):22. PubMed ID: 33786291
[TBL] [Abstract][Full Text] [Related]
15. Screening of SARS-CoV-2 antivirals through a cell-based RNA-dependent RNA polymerase (RdRp) reporter assay.
Uppal T; Tuffo K; Khaiboullina S; Reganti S; Pandori M; Verma SC
Cell Insight; 2022 Aug; 1(4):100046. PubMed ID: 37192863
[TBL] [Abstract][Full Text] [Related]
16. Denovo designing, retro-combinatorial synthesis, and molecular dynamics analysis identify novel antiviral VTRM1.1 against RNA-dependent RNA polymerase of SARS CoV2 virus.
Tiwari V
Int J Biol Macromol; 2021 Feb; 171():358-365. PubMed ID: 33421473
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) - A drug repurposing study.
Ahmad J; Ikram S; Ahmad F; Rehman IU; Mushtaq M
Heliyon; 2020 Jul; 6(7):e04502. PubMed ID: 32754651
[TBL] [Abstract][Full Text] [Related]
18. Bioactive Molecules of Tea as Potential Inhibitors for RNA-Dependent RNA Polymerase of SARS-CoV-2.
Bhardwaj VK; Singh R; Sharma J; Rajendran V; Purohit R; Kumar S
Front Med (Lausanne); 2021; 8():684020. PubMed ID: 34136511
[TBL] [Abstract][Full Text] [Related]
19. Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An
Akinlalu AO; Chamundi A; Yakumbur DT; Afolayan FID; Duru IA; Arowosegbe MA; Enejoh OA
Sci Afr; 2021 Sep; 13():e00845. PubMed ID: 34308004
[TBL] [Abstract][Full Text] [Related]
20. Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach.
Aftab SO; Ghouri MZ; Masood MU; Haider Z; Khan Z; Ahmad A; Munawar N
J Transl Med; 2020 Jul; 18(1):275. PubMed ID: 32635935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
